COMMUNIQUÉS West-GlobeNewswire

VANC Pharmaceuticals’ Vision for a New Future

03/05/2018 - 14:00

VANCOUVER, British Columbia, May 03, 2018 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. ( “VANC” ) (TSXV:VANC) (OTCQB:NUVPF) Board of Directors provided guidance on future company direction and initiatives today. “In [...]

Opiant Pharmaceuticals To Host Key Opinion Leader Meeting on Medications for Addictions and Related Disorders

03/05/2018 - 14:00

Key Opinion Leader Luncheon to Take Place in New York City on May 10 SANTA MONICA, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ: OPNT ), a specialty pharmaceutical company [...]

Caladrius Biosciences to Host First Quarter 2018 Financial Results Conference Call on Thursday, May 10, 2018 at 4:30 p.m. Eastern Time

03/05/2018 - 14:00

BASKING RIDGE, N.J., May 03, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]

Catalyst Biosciences Reports First Quarter Operating & Financial Results and Provides Corporate Update

03/05/2018 - 14:00

Announced Korean Ministry of Food and Drug Safety approval to add sixth cohort to the Phase 1/2 trial of CB 2679d/ISU304 in individuals with hemophilia B Raised approximately $106.8 million in an underwritten public [...]

Syneos Health Leaders Honored by the Healthcare Businesswomen’s Association

03/05/2018 - 14:00

RALEIGH, N.C., May 03, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq: SYNH ), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and CCO (Contract [...]

Key Biologics Accelerates CAR-T Research with New Leukaphereses Offerings

03/05/2018 - 13:45

Also announces installation of Asymptote VIA Quad Freeze controlled-rate freezer MEMPHIS, Tenn. and MONTREAL, May 03, 2018 (GLOBE NEWSWIRE) -- Key Biologics LLC , a provider of biological raw materials and services for [...]

GW Pharmaceuticals to Report Second Quarter Financial Results and Host Conference Call on 8 May, 2018

03/05/2018 - 13:37

LONDON, May 03, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its [...]

Strongbridge Biopharma plc Announces New Employment Inducement Awards

03/05/2018 - 13:30

DUBLIN, Ireland and TREVOSE, Pa., May 03, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP ), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]

Minerva Neurosciences Reports First Quarter 2018 Financial Results and Business Updates

03/05/2018 - 13:30

WALTHAM, Mass., May 03, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV ), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]

Kura Oncology to Present at Deutsche Bank 43rd Annual Health Care Conference

03/05/2018 - 13:30

SAN DIEGO, May 03, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA ), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced its [...]

Avenue Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights

03/05/2018 - 13:30

Completed enrollment in Phase 3 trial of IV tramadol for the treatment of postoperative pain following bunionectomy surgery; topline data expected in second quarter 2018 NEW YORK, May 03, 2018 (GLOBE NEWSWIRE) -- Avenue [...]

Immunovaccine Inc. Has Applied to List its Common Shares on Nasdaq, Announces Reverse Stock Split

03/05/2018 - 13:05

HALIFAX, Nova Scotia, May 03, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (“Immunovaccine” or the “Corporation”) (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immunotherapy company, announced today that it has applied to [...]

Neuralstem Announces Publication of Long-Term Follow-up Data on ALS in the Annals of Clinical and Translational Neurology

03/05/2018 - 13:00

Post-hoc comparison of combined cohorts from Phase 1 and 2 trials vs. historical controls revealed statistically significant difference in scores in functional status and in a composite statistic combining survival and [...]

Intra-Cellular Therapies Reports First Quarter 2018 Financial Results and Provides Corporate Update

03/05/2018 - 13:00

NEW YORK, May 03, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]

Codexis to Hold First Quarter 2018 Conference Call on May 10

03/05/2018 - 13:00

REDWOOD CITY, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS ), a leading protein engineering company, announces that it will report first quarter 2018 financial results after market close on [...]

PetVivo Holdings, Inc. Provides Shareholders Update

03/05/2018 - 13:00

MINNEAPOLIS, May 03, 2018 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCMarkets:PETV), an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for pets is [...]

AMAG Pharmaceuticals Announces First Quarter 2018 Financial Results and Raises Full Year Financial Guidance

03/05/2018 - 13:00

Strong first quarter execution with two FDA approvals and submission of a new drug application Conference call scheduled for 8:00 a.m. ET today WALTHAM, Mass., May 03, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc [...]

Trading by management and close relations of management

03/05/2018 - 11:41

Read the full announcement in the attached file Attachment 2018_24_Trading_by_management_EN

Esperite's (ESP) The Cell Factory received European funding to develop the 2nd generation EVs drug for treatment of Stroke

03/05/2018 - 11:37

Esperite's biotech company The Cell Factory, Belgium has received funding from the European Union's Horizon 2020 research and innovation Programme for development and characterization of the extracellular vesicles (EVs [...]